Literature DB >> 21475372

Wnt signaling in prostate development and carcinogenesis.

Gvantsa Kharaishvili1, Dana Simkova, Eka Makharoblidze, Katerina Trtkova, Zdenek Kolar, Jan Bouchal.   

Abstract

BACKGROUND: The Wnt signaling pathway is crucial for cell fate decisions, stem cell renewal, regulation of cell proliferation and differentiation. Deregulated Wnt signaling is also implicated in a number of hereditary and degenerative diseases and cancer. METHODS AND
RESULTS: This review highlights the role of the Wnt pathway in the regulation of stem/progenitor cell renewal and prostate gland development and how this signaling is altered in prostate cancer. Recent evidence suggests that Wnt signaling regulates androgen activity in prostate cancer cells, enhances androgen receptor expression and promotes the growth of prostate cancer even after androgen ablation therapy. There is also strong evidence that Wnt signaling is enhanced in androgen-ablation resistant tumors and bone metastases.
CONCLUSIONS: Further study of the modulators of this pathway will be of therapeutic relevance as inhibition of Wnt signaling may have the potential to reduce the self-renewal and aggressive behaviour of prostate cancer while Wnt signaling activation might enhance stem cell activity when tissue regeneration is required.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21475372     DOI: 10.5507/bp.2011.016

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  19 in total

Review 1.  Hedgehog signaling in prostate epithelial-mesenchymal growth regulation.

Authors:  Yu-Ching Peng; Alexandra L Joyner
Journal:  Dev Biol       Date:  2015-01-29       Impact factor: 3.582

Review 2.  SOX4: The unappreciated oncogene.

Authors:  Carlos S Moreno
Journal:  Semin Cancer Biol       Date:  2019-08-21       Impact factor: 15.707

3.  In utero exposure to TCDD alters Wnt signaling during mouse prostate development: linking ventral prostate agenesis to downregulated β-catenin signaling.

Authors:  Andrew J Schneider; Robert W Moore; Amanda M Branam; Lisa L Abler; Kimberly P Keil; Vatsal Mehta; Chad M Vezina; Richard E Peterson
Journal:  Toxicol Sci       Date:  2014-06-13       Impact factor: 4.849

4.  Oncogenic and tumor-suppressive microRNAs in prostate cancer.

Authors:  Morgan L Zenner; Bethany Baumann; Larisa Nonn
Journal:  Curr Opin Endocr Metab Res       Date:  2020-02-27

Review 5.  Why are epididymal tumours so rare?

Authors:  Ching-Hei Yeung; Kai Wang; Trevor G Cooper
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

Review 6.  MicroRNAs as biomarker and novel therapeutic target for posttraumatic stress disorder in Veterans.

Authors:  Sudhiranjan Gupta; Rakeshwar S Guleria; Yvette Z Szabo
Journal:  Psychiatry Res       Date:  2021-10-26       Impact factor: 3.222

7.  TCDD inhibition of canonical Wnt signaling disrupts prostatic bud formation in mouse urogenital sinus.

Authors:  Amanda M Branam; Nicole M Davis; Robert W Moore; Andrew J Schneider; Chad M Vezina; Richard E Peterson
Journal:  Toxicol Sci       Date:  2013-02-20       Impact factor: 4.849

8.  Esculetin suppresses proliferation of human colon cancer cells by directly targeting β-catenin.

Authors:  Sung-Young Lee; Tae-Gyu Lim; Hanyong Chen; Sung Keun Jung; Hyo-Jeong Lee; Mee-Hyun Lee; Dong Joon Kim; Aram Shin; Ki Won Lee; Ann M Bode; Young-Joon Surh; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-08

9.  Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.

Authors:  Qiang Sun; Shu Guo; Chen-Chao Wang; Xu Sun; Di Wang; Nan Xu; Shi-Feng Jin; Ke-Zhu Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

10.  Physiopathological aspects of the Wnt/β-catenin signaling pathway in the male reproductive system.

Authors:  Ana Paola G Lombardi; Carine Royer; Raisa Pisolato; Fernanda N Cavalcanti; Thaís F G Lucas; Maria Fatima M Lazari; Catarina S Porto
Journal:  Spermatogenesis       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.